Epigallocatechin-3-Gallate attenuates lipopolysacharide-induced pneumonia via modification of inflammation, oxidative stress, apoptosis, and autophagy
Article in BMC Complementary Medicine and Therapies (April 2024)
The most recent citing publications are shown below. View all 29 publications that cite this research output on Dimensions.
Article in BMC Complementary Medicine and Therapies (April 2024)
Article in F1000Research (March 2024)
Article in PLOS ONE (February 2024)